Voisard Asset Management Group, Inc. Catalyst Pharmaceuticals, Inc. Transaction History
Voisard Asset Management Group, Inc.
- $240 Billion
- Q3 2024
A detailed history of Voisard Asset Management Group, Inc. transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Voisard Asset Management Group, Inc. holds 970 shares of CPRX stock, worth $22,028. This represents 0.01% of its overall portfolio holdings.
Number of Shares
970
Previous 970
-0.0%
Holding current value
$22,028
Previous $15 Million
28.34%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding CPRX
# of Institutions
300Shares Held
97.4MCall Options Held
29.2KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$425 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.13MShares$207 Million2.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$184 Million0.0% of portfolio
-
State Street Corp Boston, MA6.03MShares$137 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$68.6 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.34B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...